Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: RAFT - Pace &Ablate [NA]

View source ↗

Summary

The RAFT - Pace & Ablate trial, sponsored by Habib Khan, is currently recruiting and targets patients with atrial fibrillation and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Habib Khan | Conditions: Atrial Fibrillation, Heart Failure | NA | Status: RECRUITING